
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Immunosuppressants for IgG4‐related disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5333448AF27BF305334400019B2937.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cochrev">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="The Cochrane Database of Systematic Reviews">
<meta name="citation_title" content="Immunosuppressants for IgG4‐related disease">
<meta name="citation_author" content="Giovanni Cagnotto">
<meta name="citation_author_institution" content="Rheumatology, Clinical Sciences Malmö, Lund University, Malmö, Sweden">
<meta name="citation_author" content="Rebecka Teresia Bäcklund">
<meta name="citation_author_institution" content="Rheumatology, Clinical Sciences Malmö, Lund University, Malmö, Sweden">
<meta name="citation_author" content="Anders Bengtsson">
<meta name="citation_author_institution" content="Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden">
<meta name="citation_author" content="Matteo Bruschettini">
<meta name="citation_author_institution" content="Cochrane Sweden, Department of Research and Education; Paediatrics, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden, Lund University, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author" content="supported by Cochrane Sweden">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="2025">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="CD016094">
<meta name="citation_doi" content="10.1002/14651858.CD016094">
<meta name="citation_pmid" content="40838448">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/pdf/CD016094.pdf">
<meta name="description" content="This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of immunosuppressants with or without corticosteroids compared to corticosteroid monotherapy for the treatment of IgG4‐related ...">
<meta name="og:title" content="Immunosuppressants for IgG4‐related disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of immunosuppressants with or without corticosteroids compared to corticosteroid monotherapy for the treatment of IgG4‐related ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368947">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/14651858.CD016094"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/CD016094.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368947%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368947/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368947/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cochrev.gif" alt="The Cochrane Database of Systematic Reviews logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to The Cochrane Database of Systematic Reviews" title="Link to The Cochrane Database of Systematic Reviews" shape="default" href="http://www.cochranelibrary.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cochrane Database Syst Rev</button></div>. 2025 Aug 21;2025(8):CD016094. doi: <a href="https://doi.org/10.1002/14651858.CD016094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/14651858.CD016094</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cochrane%20Database%20Syst%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cochrane%20Database%20Syst%20Rev%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cochrane%20Database%20Syst%20Rev%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cochrane%20Database%20Syst%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Immunosuppressants for IgG4‐related disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cagnotto%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Giovanni Cagnotto</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Giovanni Cagnotto</span></h3>
<div class="p">
<sup>1</sup>Rheumatology, Clinical Sciences Malmö, Lund University, Malmö, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cagnotto%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giovanni Cagnotto</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%A4cklund%20RT%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rebecka Teresia Bäcklund</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rebecka Teresia Bäcklund</span></h3>
<div class="p">
<sup>1</sup>Rheumatology, Clinical Sciences Malmö, Lund University, Malmö, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%A4cklund%20RT%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebecka Teresia Bäcklund</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bengtsson%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Anders Bengtsson</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Anders Bengtsson</span></h3>
<div class="p">
<sup>2</sup>Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bengtsson%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anders Bengtsson</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bruschettini%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Matteo Bruschettini</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Matteo Bruschettini</span></h3>
<div class="p">
<sup>3</sup>Cochrane Sweden, Department of Research and Education; Paediatrics, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden, Lund University, Skåne University Hospital, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bruschettini%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matteo Bruschettini</span></a>
</div>
</div>
<sup>3</sup>; <span class="collab">supported by Cochrane Sweden</span>
</div>
<div class="cg p">Editor: <span class="collab">Cochrane Central Editorial Service</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="CD016094-aff-0001">
<sup>1</sup>Rheumatology, Clinical Sciences Malmö, Lund University, Malmö, Sweden</div>
<div id="CD016094-aff-0002">
<sup>2</sup>Rheumatology, Clinical Sciences Lund, Lund University, Lund, Sweden</div>
<div id="CD016094-aff-0003">
<sup>3</sup>Cochrane Sweden, Department of Research and Education; Paediatrics, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden, Lund University, Skåne University Hospital, Lund, Sweden</div>
<div class="author-notes p">
<div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline">Giovanni Cagnotto, Rheumatology, Clinical Sciences Malmö, Lund University, Jan Waldenströms gata 1B, Malmö, 20502, Sweden. <span>giovanni.cagnotto@med.lu.se</span>.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration.</div>
<p> This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non-Commercial Licence</a> , which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. </p>
<p><em>The content of this article (as distinct from the content of the ‘Supplementary materials’, ‘Related’ and ‘About this Review’ sections) has been peer reviewed and prepared for publication in accordance with</em><a href="https://www.cochranelibrary.com/cdsr/editorial-policies" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Cochrane’s editorial policies</a><em>. Though the aim of these processes is, among other things, to check the accuracy of such content, responsibility for the content remains that of the author(s) and Cochrane gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, the content of the article.</em></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368947  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40838448/" class="usa-link">40838448</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Objectives</h2>
<p>This is a protocol for a Cochrane Review (intervention). The objectives are as follows:</p>
<p>To assess the benefits and harms of immunosuppressants with or without corticosteroids compared to corticosteroid monotherapy for the treatment of IgG4‐related disease in people 18 years or older.</p></section><section id="CD016094-sec1-0001"><h2 class="pmc_sec_title">Background</h2>
<section id="CD016094-sec2-0001"><h3 class="pmc_sec_title">Description of the condition</h3>
<p>IgG4‐related disease is an immune‐mediated fibro‐inflammatory condition that usually involves two or more organs, either simultaneously or in a metachronous pattern [<a href="#CD016094-bib-0001" class="usa-link" aria-describedby="CD016094-bib-0001">1</a>, <a href="#CD016094-bib-0002" class="usa-link" aria-describedby="CD016094-bib-0002">2</a>, <a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>]. Any organ of the body may be affected by the disease [<a href="#CD016094-bib-0004" class="usa-link" aria-describedby="CD016094-bib-0004">4</a>]; however, the pancreas, biliary tract, salivary and lacrimal glands, orbits, retroperitoneum and aorta, kidneys, lungs, meninges, and thyroid gland are organs that are more frequently involved [<a href="#CD016094-bib-0005" class="usa-link" aria-describedby="CD016094-bib-0005">5</a>, <a href="#CD016094-bib-0006" class="usa-link" aria-describedby="CD016094-bib-0006">6</a>]. Swelling of the involved organs is the typical manifestation, and it is usually associated with elevation of serum IgG4 subclass levels [<a href="#CD016094-bib-0004" class="usa-link" aria-describedby="CD016094-bib-0004">4</a>]. Diagnosis is usually confirmed by histological examination of the swollen organ, which typically shows a dense lymphoplasmacytic infiltrate with a high number of IgG4‐positive plasma cells, significant fibrosis with a so‐called 'storiform' pattern, and obliterative phlebitis [<a href="#CD016094-bib-0002" class="usa-link" aria-describedby="CD016094-bib-0002">2</a>, <a href="#CD016094-bib-0007" class="usa-link" aria-describedby="CD016094-bib-0007">7</a>].</p>
<p>Disease progression is slow, but may lead to organ damage and failure due to advanced fibrosis [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>, <a href="#CD016094-bib-0004" class="usa-link" aria-describedby="CD016094-bib-0004">4</a>]. IgG4‐related disease usually responds to corticosteroid treatment [<a href="#CD016094-bib-0008" class="usa-link" aria-describedby="CD016094-bib-0008">8</a>], but relapses are common during treatment tapering [<a href="#CD016094-bib-0009" class="usa-link" aria-describedby="CD016094-bib-0009">9</a>, <a href="#CD016094-bib-0010" class="usa-link" aria-describedby="CD016094-bib-0010">10</a>]. Immunosuppressants are often combined with corticosteroids to reduce the number of relapses, thereby reducing the extent of organ damage and the well‐known adverse effects of prolonged corticosteroid treatment [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>, <a href="#CD016094-bib-0011" class="usa-link" aria-describedby="CD016094-bib-0011">11</a>]. However, convincing evidence for this combination treatment strategy is lacking [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>], as are extensive epidemiological studies on IgG4‐related disease. A Japanese survey estimated an incidence of 0.28 to 1.08 per 100,000 person‐years and an estimated prevalence of 6.2 per 100,000 subjects in Japan [<a href="#CD016094-bib-0012" class="usa-link" aria-describedby="CD016094-bib-0012">12</a>]. A more recent American retrospective cohort study showed an incidence of 1.39 per 100,000 person‐years and a prevalence of 5.3 per 100,000 subjects in the USA [<a href="#CD016094-bib-0013" class="usa-link" aria-describedby="CD016094-bib-0013">13</a>]. IgG4‐related disease has a male predominance and typically affects middle‐aged and older individuals, with an average age at diagnosis ranging from 50 to 70 years [<a href="#CD016094-bib-0008" class="usa-link" aria-describedby="CD016094-bib-0008">8</a>, <a href="#CD016094-bib-0014" class="usa-link" aria-describedby="CD016094-bib-0014">14</a>, <a href="#CD016094-bib-0015" class="usa-link" aria-describedby="CD016094-bib-0015">15</a>, <a href="#CD016094-bib-0016" class="usa-link" aria-describedby="CD016094-bib-0016">16</a>]. The disease is generally more severe in males than females [<a href="#CD016094-bib-0017" class="usa-link" aria-describedby="CD016094-bib-0017">17</a>].</p></section><section id="CD016094-sec2-0002"><h3 class="pmc_sec_title">Description of the intervention and how it might work</h3>
<p>The typical lesions of IgG4‐related disease are characterised by prominent inflammatory infiltrates [<a href="#CD016094-bib-0004" class="usa-link" aria-describedby="CD016094-bib-0004">4</a>]; therefore, the disease responds well to the anti‐inflammatory effects of corticosteroids. Although the pathophysiology of this condition is still not completely understood, experimental data suggest that activation of both innate and adaptive immune responses is a hallmark of IgG‐related disease, likely contributing to the fibro‐inflammatory process [<a href="#CD016094-bib-0005" class="usa-link" aria-describedby="CD016094-bib-0005">5</a>, <a href="#CD016094-bib-0018" class="usa-link" aria-describedby="CD016094-bib-0018">18</a>, <a href="#CD016094-bib-0019" class="usa-link" aria-describedby="CD016094-bib-0019">19</a>, <a href="#CD016094-bib-0020" class="usa-link" aria-describedby="CD016094-bib-0020">20</a>, <a href="#CD016094-bib-0021" class="usa-link" aria-describedby="CD016094-bib-0021">21</a>, <a href="#CD016094-bib-0022" class="usa-link" aria-describedby="CD016094-bib-0022">22</a>]. Treatment with immunosuppressants targeting different components of the immune system may therefore be beneficial. In particular, biologic agents may act through various mechanisms, including B cell depletion, such as with rituximab (anti‐CD20) and inebilizumab (anti‐CD19), cytokine inhibition, such as with tocilizumab (anti‐IL‐6), or interference with T cell co‐stimulation, as with abatacept, a CTLA‐4–Ig fusion protein that modulates the CD80/CD86‐CD28 pathway. Conventional synthetic disease‐modifying anti‐rheumatic drugs (csDMARDs), such as methotrexate and mycophenolate mofetil, exert immunomodulatory effects by interfering with lymphocyte function and inflammatory cytokine production. In addition, small molecule inhibitors such as baricitinib, a Janus kinase (JAK) inhibitor, and rilzabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, act by blocking intracellular signalling pathways involved in immune cell activation and cytokine production. These mechanisms may lead to disease remission, a reduction in the frequency of disease flares, a lower cumulative corticosteroid dose, and an overall improvement in the quality of life (QoL) for people with IgG4‐related disease. However, immunosuppressive treatments may also carry risks, such as increased susceptibility to serious infection, especially in the elderly, as well as an increased risk of malignancies [<a href="#CD016094-bib-0023" class="usa-link" aria-describedby="CD016094-bib-0023">23</a>, <a href="#CD016094-bib-0024" class="usa-link" aria-describedby="CD016094-bib-0024">24</a>, <a href="#CD016094-bib-0025" class="usa-link" aria-describedby="CD016094-bib-0025">25</a>, <a href="#CD016094-bib-0026" class="usa-link" aria-describedby="CD016094-bib-0026">26</a>].</p></section><section id="CD016094-sec2-0003"><h3 class="pmc_sec_title">Why it is important to do this review</h3>
<p>IgG4‐related disease was recognised as a distinct disease only 20 years ago [<a href="#CD016094-bib-0027" class="usa-link" aria-describedby="CD016094-bib-0027">27</a>]. Since then, investigators have been trying to describe the wide spectrum of this clinical entity, as well as working to understand the pathophysiology of this disease. The recent development of comprehensive classification criteria has led to an increased interest in the disease [<a href="#CD016094-bib-0006" class="usa-link" aria-describedby="CD016094-bib-0006">6</a>]. Clinical trials have recently been conducted, and new promising drugs are in the pipeline. However, due to the complexity of the disease and its recent identification, little is known about the best treatment strategies to adopt, and no approved medications for the treatment of this disease are currently available. IgG4‐related disease typically responds well to corticosteroids; however, disease flares are common during corticosteroid tapering, and the optimal tapering regimen remains uncertain. Moreover, prolonged treatment with corticosteroids might lead to untoward adverse effects [<a href="#CD016094-bib-0028" class="usa-link" aria-describedby="CD016094-bib-0028">28</a>]. Therefore, clinicians often use different immunosuppressants in combination with corticosteroids; however, it is unclear whether these treatment strategies are effective and safe [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>, <a href="#CD016094-bib-0011" class="usa-link" aria-describedby="CD016094-bib-0011">11</a>]. A previous systematic review using network meta‐analysis investigated the use of immunosuppressants in IgG4‐related disease. The authors performed a literature search up to February 2019 and only included observational studies; thus, the generated evidence was of low quality [<a href="#CD016094-bib-0029" class="usa-link" aria-describedby="CD016094-bib-0029">29</a>]. Hence, current treatment recommendations are primarily based on observational studies and expert opinion [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>], highlighting the need for high‐quality evidence on the management of IgG4‐related disease to address this knowledge gap. Given the recent increased awareness of the disease, the recent publication of classification criteria [<a href="#CD016094-bib-0006" class="usa-link" aria-describedby="CD016094-bib-0006">6</a>], and the surge in the conduct of randomised controlled studies (RCTs), we believe it is now appropriate to undertake this Cochrane systematic review, aiming to generate high‐quality evidence that can be useful for clinicians and people dealing with this disease.</p></section></section><section id="CD016094-sec1-0002"><h2 class="pmc_sec_title">Objectives</h2>
<p>To assess the benefits and harms of immunosuppressants with or without corticosteroids compared to corticosteroid monotherapy for the treatment of IgG4‐related disease in people 18 years or older.</p></section><section id="CD016094-sec1-0003"><h2 class="pmc_sec_title">Methods</h2>
<section id="CD016094-sec2-0004"><h3 class="pmc_sec_title">Criteria for considering studies for this review</h3>
<p>We will follow the methodological guidance from the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0030" class="usa-link" aria-describedby="CD016094-bib-0030">30</a>] and Methodological Expectations for Cochrane Intervention Reviews [<a href="#CD016094-bib-0031" class="usa-link" aria-describedby="CD016094-bib-0031">31</a>]. We will report the review following PRISMA guidelines [<a href="#CD016094-bib-0030" class="usa-link" aria-describedby="CD016094-bib-0030">30</a>, <a href="#CD016094-bib-0032" class="usa-link" aria-describedby="CD016094-bib-0032">32</a>, <a href="#CD016094-bib-0033" class="usa-link" aria-describedby="CD016094-bib-0033">33</a>].</p>
<section id="CD016094-sec3-0001"><h4 class="pmc_sec_title">Types of studies</h4>
<p>We will include the following studies.</p>
<ul class="list" style="list-style-type:disc">
<li><p>RCTs, quasi‐RCTs (i.e. parallel‐arm RCTs in which allocation is decided by an approximation of randomisation, e.g. allocation by participant ID number), and cross‐over RCTs.</p></li>
<li><p>Studies reported as full text, those published only as abstracts, and unpublished data.</p></li>
</ul>
<p>We will not include cluster RCTs.</p>
<p>We will not use reporting of our chosen outcomes as a criterion for including or excluding studies.</p>
<p>We will not impose any language restrictions.</p></section><section id="CD016094-sec3-0002"><h4 class="pmc_sec_title">Types of participants</h4>
<p>We will include participants aged 18 years or older with a diagnosis of IgG4‐related disease (also called: IgG4‐associated multifocal systemic fibrosis, IgG4‐related systemic disease, IgG4‐related sclerosing disease, hyper‐IgG4 disease, IgG4‐related disease, systemic IgG4 plasmacytic syndrome, IgG4‐related multi‐organ lymphoproliferative syndrome, IgG4‐associated disease) according to the 2011 comprehensive diagnostic criteria [<a href="#CD016094-bib-0034" class="usa-link" aria-describedby="CD016094-bib-0034">34</a>], the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2019 classification criteria [<a href="#CD016094-bib-0006" class="usa-link" aria-describedby="CD016094-bib-0006">6</a>], or the 2020 revised comprehensive diagnostic criteria [<a href="#CD016094-bib-0035" class="usa-link" aria-describedby="CD016094-bib-0035">35</a>].</p>
<p>Participants with single organ disease that do not satisfy the above criteria will be included if they fulfil any of the following organ‐specific diagnostic criteria:</p>
<ul class="list" style="list-style-type:disc">
<li><p>IgG4‐related autoimmune pancreatitis [<a href="#CD016094-bib-0036" class="usa-link" aria-describedby="CD016094-bib-0036">36</a>]</p></li>
<li><p>IgG4‐related lacrimal gland and saliva adenitis [<a href="#CD016094-bib-0037" class="usa-link" aria-describedby="CD016094-bib-0037">37</a>]</p></li>
<li><p>IgG4‐related kidney disease [<a href="#CD016094-bib-0038" class="usa-link" aria-describedby="CD016094-bib-0038">38</a>]</p></li>
<li><p>IgG4‐related sclerosing cholangitis [<a href="#CD016094-bib-0039" class="usa-link" aria-describedby="CD016094-bib-0039">39</a>]</p></li>
<li><p>IgG4‐related ophthalmic disease [<a href="#CD016094-bib-0040" class="usa-link" aria-describedby="CD016094-bib-0040">40</a>]</p></li>
<li><p>IgG4‐related respiratory disease [<a href="#CD016094-bib-0041" class="usa-link" aria-describedby="CD016094-bib-0041">41</a>]</p></li>
<li><p>IgG4‐related large periarteritis/periarteritis and retroperitoneal fibrosis [<a href="#CD016094-bib-0042" class="usa-link" aria-describedby="CD016094-bib-0042">42</a>].</p></li>
</ul>
<p>Studies including participants younger than 18 will be included, provided the proportion of participants aged 18 years or older is equal to or more than 80%.</p>
<p>We will not apply any restrictions to study settings (e.g. outpatients, hospitalised patients).</p>
<p>Both participants with active disease and those with disease in remission will be included.</p></section><section id="CD016094-sec3-0003"><h4 class="pmc_sec_title">Types of interventions</h4>
<p>We will include studies investigating the following treatments (either as monotherapy or in combination with corticosteroids).</p>
<ul class="list" style="list-style-type:disc">
<li><p>Biologics: including but not limited to abatacept, rituximab, tocilizumab, tumour necrosis factor inhibitors</p></li>
<li><p>csDMARDs: including but not limited to azathioprine, iguratimod, leflunomide, methotrexate, mycophenolate mofetil, cyclophosphamide</p></li>
<li><p>JAK inhibitors: including but not limited to baricitinib, filgotinib, tofacitinib</p></li>
<li><p>BTK inhibitors: including but not limited to rilzabrutinib, zanubrutinib.</p></li>
</ul>
<p>The comparator of interest is corticosteroid monotherapy.</p>
<p>We will pool different doses and routes of administration of the same interventions (e.g. we will pool rituximab 500 mg and rituximab 1000 mg; intravenous tocilizumab and subcutaneous tocilizumab).</p>
<p>We will not impose any limitations on the dose or route of administration of the interventions and comparisons.</p></section></section><section id="CD016094-sec2-0005"><h3 class="pmc_sec_title">Outcome measures</h3>
<p>IgG4‐related disease is a recently identified disease; therefore, no recommended outcomes for clinical trials have been established. We will adopt outcomes deemed clinically important by the medical community with experience in IgG4‐related diseases, and outcomes that are used in other rheumatic diseases which are similar to IgG4‐related disease [<a href="#CD016094-bib-0003" class="usa-link" aria-describedby="CD016094-bib-0003">3</a>, <a href="#CD016094-bib-0043" class="usa-link" aria-describedby="CD016094-bib-0043">43</a>, <a href="#CD016094-bib-0044" class="usa-link" aria-describedby="CD016094-bib-0044">44</a>, <a href="#CD016094-bib-0045" class="usa-link" aria-describedby="CD016094-bib-0045">45</a>]. When feasible, we will use outcome measures that are based on the validated IgG4‐related disease responder index [<a href="#CD016094-bib-0046" class="usa-link" aria-describedby="CD016094-bib-0046">46</a>, <a href="#CD016094-bib-0047" class="usa-link" aria-describedby="CD016094-bib-0047">47</a>].</p>
<section id="CD016094-sec3-0004"><h4 class="pmc_sec_title">Critical outcomes</h4>
<ol class="list" style="list-style-type:decimal">
<li><p>Disease flares</p></li>
<li><p>Disease remission</p></li>
<li><p>Health‐related QoL (HRQoL)</p></li>
<li><p>Withdrawal due to adverse events</p></li>
<li><p>Serious adverse events.</p></li>
</ol>
<section id="CD016094-sec4-0001"><h5 class="pmc_sec_title">Definition of outcomes and endpoints</h5>
<section id="CD016094-sec5-0001"><h6 class="pmc_sec_title">1. Disease flares</h6>
<p>Disease flares are defined as an exacerbation of the disease after an initial improvement. It will be measured as time to first flare, as defined by the trialists.</p></section><section id="CD016094-sec5-0002"><h6 class="pmc_sec_title">2. Disease remission</h6>
<p>Disease remission is defined as a state of absence of active disease. It will be measured as the proportion of participants with inactive disease, as defined by the trialists.</p></section><section id="CD016094-sec5-0003"><h6 class="pmc_sec_title">3. HRQoL</h6>
<p>HRQoL is defined as a <em>"</em>multidomain concept that represents the patient’s general perception of the effect of illness and treatment on physical, psychological, and social aspects of life<em>"</em> [<a href="#CD016094-bib-0048" class="usa-link" aria-describedby="CD016094-bib-0048">48</a>]. For the purpose of this review, HRQoL will be measured by the 36‐Item Short Form Health Survey Mental Component Summary Score (SF‐36 MCS) [<a href="#CD016094-bib-0049" class="usa-link" aria-describedby="CD016094-bib-0049">49</a>] or by the EQ‐5D‐5L [<a href="#CD016094-bib-0050" class="usa-link" aria-describedby="CD016094-bib-0050">50</a>].</p></section><section id="CD016094-sec5-0004"><h6 class="pmc_sec_title">4. Withdrawal due to adverse events</h6>
<p>An adverse event is defined as any untoward medical occurrence in a clinical investigation subject administered a pharmaceutical product, and which does not necessarily have to have a causal relationship with this treatment [<a href="#CD016094-bib-0051" class="usa-link" aria-describedby="CD016094-bib-0051">51</a>]. Withdrawal due to adverse events will be measured as the proportion of participants who withdraw from the study treatment due to an adverse event, according to the trialists.</p></section><section id="CD016094-sec5-0005"><h6 class="pmc_sec_title">5. Serious adverse events</h6>
<p>A serious adverse event is defined as any untoward medical occurrence that meets any of the following criteria [<a href="#CD016094-bib-0051" class="usa-link" aria-describedby="CD016094-bib-0051">51</a>].</p>
<ul class="list" style="list-style-type:disc">
<li><p>Results in death</p></li>
<li><p>Life‐threatening</p></li>
<li><p>Requires inpatient hospitalisation or prolongation of existing hospitalisation</p></li>
<li><p>Results in persistent or significant disability or incapacity</p></li>
<li><p>Congenital anomaly or birth defect in the offspring of a study participant.</p></li>
</ul>
<p>Serious adverse events will be measured as the proportion of participants experiencing at least one serious adverse event, according to the trialists.</p></section></section><section id="CD016094-sec4-0002"><h5 class="pmc_sec_title">Time points for outcome assessment</h5>
<p>The chosen outcomes will be evaluated at the latest available time point of each trial.</p></section></section><section id="CD016094-sec3-0005"><h4 class="pmc_sec_title">Important outcomes</h4>
<p>These outcomes are important to users of the review.</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Disease response</p></li>
<li><p>Cumulative steroid dose.</p></li>
</ol>
<section id="CD016094-sec4-0003"><h5 class="pmc_sec_title">Definition of outcomes and endpoints</h5>
<section id="CD016094-sec5-0006"><h6 class="pmc_sec_title">1. Disease response</h6>
<p>Disease response is defined as an objective improvement of the disease. It will be measured as the proportion of participants with improvement in the disease, as defined by the trialists and preferably by the IgG4‐related disease responder index. Disease response will be evaluated at the latest available time point for each trial.</p></section><section id="CD016094-sec5-0007"><h6 class="pmc_sec_title">2. Cumulative steroid dose</h6>
<p>Cumulative steroid dose will be reported as the mean dose of prednisolone equivalents. This outcome will be evaluated at the latest available time point for each trial.</p></section></section></section></section><section id="CD016094-sec2-0006"><h3 class="pmc_sec_title">Search methods for identification of studies</h3>
<section id="CD016094-sec3-0006"><h4 class="pmc_sec_title">Electronic searches</h4>
<p>We will search the Cochrane Central Register of Controlled Trials (www.cochranelibrary.com), MEDLINE (Pubmed), Embase (Embase.com).</p>
<p>We will search the following trial registers: the U.S. National Institutes of Health clinical trials registry (clinicaltrials.gov), the EU Clinical Trials Register (eudract.ema.europa.eu), and the World Health Organization (WHO) trials portal (trialsearch.who.int).</p>
<p>For assessment of adverse events, we will also search for the websites of the regulatory agencies U.S. Food and Drug Administration‐MedWatch (www.fda.gov/safety/medwatch‐fda‐safety‐information‐and‐adverse‐event‐reporting‐program), European Medicines Evaluation Agency (www.ema.europa.eu), Australian Adverse Drug Reactions Bulletin (www.tga.gov.au/safety), and UK Medicines and Healthcare products Regulatory Agency for pharmacovigilance and drug safety updates (www.mhra.gov.uk).</p>
<p>We will search all databases from their inception to the present, and we will pose no language restrictions.</p>
<p>The search strategy is detailed in <a href="#CD016094-supitem-0001" class="usa-link">Supplementary material 1</a>.</p></section><section id="CD016094-sec3-0007"><h4 class="pmc_sec_title">Searching other resources</h4>
<p>We will check reference lists of all primary studies and review articles for additional references. We will search relevant manufacturer websites for trial information. We will search for errata or retractions from included studies published in full text on PubMed (www.ncbi.nlm.nih.gov/pubmed), and report the date this was done within the review.</p></section></section><section id="CD016094-sec2-0007"><h3 class="pmc_sec_title">Data collection and analysis</h3>
<section id="CD016094-sec3-0008"><h4 class="pmc_sec_title">Selection of studies</h4>
<p>Two review authors (GC, RTB) will independently screen titles and abstracts for inclusion of all the potentially relevant studies we identify as a result of the search, and code them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We will retrieve the full‐text study report publications, and two review authors (GC, RTB) will independently screen the full‐text and identify studies for inclusion, and identify and record reasons for exclusion of the ineligible studies. We will resolve any disagreement through discussion or, if required, we will consult a third review author (MB or AB). If necessary, we will contact study authors by email to obtain missing information relevant to determining study eligibility. We will identify and exclude duplicates and collate multiple reports of the same study so that each study, rather than each report, is the unit of interest in the review. We will record the selection process in sufficient detail to complete a PRISMA flow diagram [<a href="#CD016094-bib-0032" class="usa-link" aria-describedby="CD016094-bib-0032">32</a>], and the 'Characteristics of excluded studies' table.</p>
<p>We will manage the results of the search using Covidence [<a href="#CD016094-bib-0052" class="usa-link" aria-describedby="CD016094-bib-0052">52</a>].</p></section><section id="CD016094-sec3-0009"><h4 class="pmc_sec_title">Data extraction and management</h4>
<p>We will use a data collection form for study characteristics and outcome data, which we will pilot‐test on at least one included study in the review. One review author (GC) will extract study characteristics from the included studies. A second review author (RTB) will spot‐check study characteristics for accuracy against the trial report. We will extract the following study characteristics.</p>
<ul class="list" style="list-style-type:disc">
<li><p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and location, study setting, withdrawals, and date of study.</p></li>
<li><p>Participants: number, mean age, age range, sex, disease duration, severity of condition, diagnostic criteria, inclusion criteria, and exclusion criteria.</p></li>
<li><p>Interventions: intervention (including dose, route of administration and duration), comparison (including dose, route of administration and duration), concomitant medications, and excluded medications.</p></li>
<li><p>Outcomes: critical and important outcomes specified and collected, and time points reported.</p></li>
<li><p>Characteristics of the design of the study as outlined below in the <a href="#CD016094-sec3-0010" class="usa-link">Risk of bias assessment in included studies</a> section</p></li>
<li><p>Notes: study funding and notable declarations of interest of trial authors.</p></li>
</ul>
<p>Two review authors (GC, RTB) will independently extract outcome data from the included studies. We will extract the number of events and number of participants per treatment group for dichotomous outcomes, and the means, standard deviations and number of participants per treatment group for continuous outcomes. We will extract the number of participants, hazard ratios (HRs) and standard errors for time‐to‐event data (e.g. disease flares). If necessary, we will extract HRs from Kaplan‐Meier curves or from other statistics in each study, using standard methods [<a href="#CD016094-bib-0053" class="usa-link" aria-describedby="CD016094-bib-0053">53</a>]. We will note in the 'Characteristics of included studies' table if outcome data were not reported in a usable way, and when data were transformed or estimated from a graph. We will resolve disagreements by consensus or by involving a third review author (AB). One review author (GC) will transfer data into Review Manager [<a href="#CD016094-bib-0054" class="usa-link" aria-describedby="CD016094-bib-0054">54</a>]. We will double‐check that the data are entered correctly by comparing the data presented in the systematic review with the study reports. Should any queries arise, or in cases where additional data are required, we will contact study investigators by email for clarification. We will use PlotDigitizer (PlotDigitizer — Extract Data from Graph Image Online) to extract data from graphs or figures. These data will also be extracted in duplicate. We will analyse all participants randomised on an intention‐to‐treat (ITT) basis.</p>
<p>Where reports include multiple measures of a single outcome, our order of preference will be as follows.</p>
<p>Disease flares</p>
<ul class="list" style="list-style-type:disc">
<li><p>The definition of flare reported by the trialists and based on the IgG4‐related disease responder index [<a href="#CD016094-bib-0046" class="usa-link" aria-describedby="CD016094-bib-0046">46</a>, <a href="#CD016094-bib-0047" class="usa-link" aria-describedby="CD016094-bib-0047">47</a>].</p></li>
<li><p>The definition of flare reported by the trialists that correlates best with the definition reported in other included studies.</p></li>
</ul>
<p>Disease remission</p>
<ul class="list" style="list-style-type:disc">
<li><p>The definition of remission reported by the trialists and based on the IgG4‐related disease responder index.</p></li>
<li><p>The most stringent definition of remission provided by the trialists and that correlates best with the definition reported in other included studies.</p></li>
</ul>
<p>HRQoL</p>
<ul class="list" style="list-style-type:disc">
<li><p>SF‐36 MCS</p></li>
<li><p>EQ‐5D‐5L.</p></li>
</ul>
<p>Disease response</p>
<ul class="list" style="list-style-type:disc">
<li><p>The definition of disease response reported by the trialists and based on the IgG4‐related disease responder index.</p></li>
<li><p>The less stringent definition of disease response reported by the trialists and that correlates best with the definition reported in other included studies.</p></li>
</ul></section><section id="CD016094-sec3-0010"><h4 class="pmc_sec_title">Risk of bias assessment in included studies</h4>
<p>Two review authors (GC, RTB) will independently assess the risk of bias (RoB) in each included study for each specific outcome to which the same study contributes, using the RoB 2 tool [<a href="#CD016094-bib-0055" class="usa-link" aria-describedby="CD016094-bib-0055">55</a>] and the criteria outlined in the <em>Cochrane Handbook for Systematic Reviews of Intervention</em> [<a href="#CD016094-bib-0056" class="usa-link" aria-describedby="CD016094-bib-0056">56</a>]. Any disagreements will be resolved through discussion or by involving another review author (MB).</p>
<p>We will investigate the effect of assignment to the intervention.</p>
<p>The following domains will be considered.</p>
<ul class="list" style="list-style-type:disc">
<li><p>Bias arising from the randomisation process</p></li>
<li><p>Bias due to deviations from the intended interventions (effect of assignment to intervention)</p></li>
<li><p>Bias due to missing outcome data</p></li>
<li><p>Bias in the measurement of the outcome</p></li>
<li><p>Bias in the selection of the reported result.</p></li>
</ul>
<p>RoB assessment will be applied to all the critical outcomes. Each potential source of bias will be classified as 'high risk', 'low risk', or 'some concerns', and a justification will be provided for each judgment in the RoB table. A summary of our judgments across studies for each of the five domains listed will be provided.</p>
<p>Overall RoB judgment will be provided for each study, according to the following rules [<a href="#CD016094-bib-0056" class="usa-link" aria-describedby="CD016094-bib-0056">56</a>].</p>
<ul class="list" style="list-style-type:disc">
<li><p>Low risk: the study is judged to be at low risk for all domains for the considered outcome</p></li>
<li><p>Some concerns: the study is judged to raise some concerns in at least one domain for the considered outcome, but is not at high risk for any domain</p></li>
<li><p>High risk: the study is judged to be at high risk in at least one domain for the considered outcome or when the study is judged to have some concerns for multiple domains in a way that substantially reduces confidence in the outcome.</p></li>
</ul>
<p>We will contact study authors by email to obtain clarification of potential inconsistencies in relevant information for RoB.</p>
<p>Where information on RoB is related to unpublished data or is obtained by correspondence with a trialist, we will note this in the 'Risk of bias' table.</p>
<p>A RoB graph and RoB summary will be presented for each outcome considered in the review.</p>
<section id="CD016094-sec4-0004"><h5 class="pmc_sec_title">Assessment of bias in conducting the systematic review</h5>
<p>We will conduct the review according to this published protocol. Any deviations will be reported in the 'Differences between protocol and review' section of the systematic review.</p></section></section><section id="CD016094-sec3-0011"><h4 class="pmc_sec_title">Measures of treatment effect</h4>
<p>We will analyse dichotomous data as risk ratios (RRs) or Peto odds ratios (ORs) when the outcome is a rare event (approximately &lt; 10%), and use 95% confidence intervals (CIs). Time‐to‐event data (e.g. disease flares) will be analysed as HRs and 95% CIs, whereas continuous data will be analysed by the mean difference (MD) and 95% CIs. We will enter data presented as a scale with a consistent direction of effect across studies.</p>
<p>When different scales are used to measure the same conceptual outcome (e.g. HRQoL), standardised mean differences (SMDs) will be calculated, with corresponding 95% CIs. SMDs will be back‐translated to a typical scale (e.g. 0 to 100 for HRQoL) by multiplying the SMD by a typical among‐person standard deviation (e.g. the standard deviation of the control group at baseline from the most representative trial) as per the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0057" class="usa-link" aria-describedby="CD016094-bib-0057">57</a>].</p>
<p>In the 'Effect of interventions' section and the 'Comments' column of the summary of findings table, we will provide the absolute per cent difference and the relative per cent change from baseline risk for dichotomous outcomes. We will calculate the absolute per cent change from the difference in the risks between the intervention and control group using GRADEpro GDT [<a href="#CD016094-bib-0058" class="usa-link" aria-describedby="CD016094-bib-0058">58</a>] and expressed as a percentage. The relative per cent change for dichotomous data will be calculated as the RR ‐ 1 and expressed as a percentage.</p>
<p>In the 'Effect of interventions' section and the 'Comments' column of the summary of findings table, we will provide the absolute risk of flare‐free survival for time‐to‐event data. We will calculate the intervention risk using the method by Tierney and colleagues [<a href="#CD016094-bib-0059" class="usa-link" aria-describedby="CD016094-bib-0059">59</a>].</p>
<p>In the 'Effect of interventions' section and the 'Comments' column of the summary of findings tables, we will provide the absolute benefit of continuous outcomes, which will be calculated as the improvement in the intervention group minus the improvement in the control group, expressed in the original units.</p>
<p>When interpreting HRQoL, we will use +2.4 and ‐1.2 points of SF‐36 MCS as minimal clinically important difference (MCID) for improvement and worsening, respectively. These cut‐offs were calculated in a cohort of individuals with systemic lupus erythematosus (SLE) by Colangelo and colleagues [<a href="#CD016094-bib-0060" class="usa-link" aria-describedby="CD016094-bib-0060">60</a>]. SLE is a chronic autoimmune disease, and, like IgG4‐related disease, it usually involves multiple organs. Given the similarities between these two diseases, and due to the lack of an established MCID of SF‐36 for IgG4‐related disease, we find it appropriate to use the cut‐offs reported above in our review.</p></section><section id="CD016094-sec3-0012"><h4 class="pmc_sec_title">Unit of analysis issues</h4>
<p>Where multiple trial arms are reported in a single trial, we will include only the relevant arms. If two comparisons are combined in the same meta‐analysis, we will halve the control group to avoid double‐counting. In the event that we identify cross‐over trials, in which the reporting of continuous outcome data precludes paired analysis, we will not include these data in a meta‐analysis, in order to avoid unit of analysis error. Where carry‐over effects are thought to exist, and where sufficient data exists, we will only include data from the first period in the analysis.</p></section><section id="CD016094-sec3-0013"><h4 class="pmc_sec_title">Dealing with missing data</h4>
<p>Where possible, we will contact investigators or study sponsors by email to verify key study characteristics and obtain missing numerical outcome data (e.g. when a study is identified as abstract only, or when data is not available for all participants). Where this is not possible, and the missing data are thought to introduce serious bias, we will explore the impact of including such studies in the overall assessment of results by a sensitivity analysis. Any assumptions and imputations used to handle missing data will be clearly described, and the effect of imputation will be explored by sensitivity analyses. For dichotomous outcomes (e.g. disease remission), the denominator will be the number of participants in each group for which the outcome was measured. If this number is not available, we will use the number of participants randomised in each intervention group as the denominator. For continuous outcomes (e.g. HRQoL), we will calculate the MD or SMD based on the number of participants analysed at that time point. If the number of participants analysed is not presented for each time point, the number of randomised participants in each group at baseline will be used. For time‐to‐event data, HR will be calculated based on the number of randomised participants in each treatment arm. Where possible, missing standard deviations will be computed from other statistics such as standard errors, CIs or P values, according to the methods recommended in the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0030" class="usa-link" aria-describedby="CD016094-bib-0030">30</a>]. If standard deviations cannot be calculated, they will be imputed (e.g. from other studies in the meta‐analysis). For outcomes assessing adverse events, we will extract data for those randomised to and receiving the allocated treatment or comparison.</p></section><section id="CD016094-sec3-0014"><h4 class="pmc_sec_title">Reporting bias assessment</h4>
<p>To assess outcome reporting bias, two authors (GC, RTB) will check trial protocols against published reports. We will search the WHO International Clinical Trials Registry Platform (<a href="https://trialsearch.who.int" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://trialsearch.who.int</a>), and the U.S. National Institutes of Health clinical trials registry (<a href="https://clinicaltrials.gov" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov</a>) for the a priori trial protocol. If trial protocols are unavailable, we will compare the outcomes reported in the methods and results sections of the trial reports. We will generate funnel plots for meta‐analyses, including at least 10 trials of varying sizes to assess the effects of small studies. If we detect asymmetry in the funnel plot, we will review the characteristics of the trials to assess whether the asymmetry is likely due to publication bias or other factors, such as the methodological or clinical diversity of the trials. Where we are able to pool more than 10 trials, we will conduct formal statistical tests to investigate funnel plot asymmetry and follow the recommendations in Chapter 13 of the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0061" class="usa-link" aria-describedby="CD016094-bib-0061">61</a>].</p></section><section id="CD016094-sec3-0015"><h4 class="pmc_sec_title">Synthesis methods</h4>
<p>We will undertake meta‐analyses only where this is meaningful, that is, if the treatments, participants and the underlying clinical question are similar enough for pooling to make sense. If a meta‐analysis is not possible, we will undertake a narrative description of the studies included in the review, following the Synthesis Without Meta‐analysis (SWiM) reporting guidelines [<a href="#CD016094-bib-0062" class="usa-link" aria-describedby="CD016094-bib-0062">62</a>].</p>
<p>We will pool different doses and routes of administration of the same drug (e.g. rituximab 1000 mg and rituximab 500 mg; intravenous tocilizumab and subcutaneous tocilizumab).</p>
<p>We will use a random‐effects model in the primary analysis, since we expect differences in treatment effect across studies, due to the heterogeneity of the disease and the heterogeneity of drugs within each intervention group. We will also perform a sensitivity analysis using a fixed‐effect model.</p>
<p>The primary analysis will include all the studies, with outcomes assessed at the latest available time point for each study. This approach should maximise statistical power.</p>
<p>The planned comparisons are (in order of importance):</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Biologic monotherapy or combined with corticosteroids versus corticosteroid monotherapy</p></li>
<li><p>csDMARD monotherapy or combined with corticosteroids versus corticosteroid monotherapy</p></li>
<li><p>JAK‐inhibitor monotherapy or combined with corticosteroids versus corticosteroid monotherapy</p></li>
<li><p>BTK‐inhibitor monotherapy or combined with corticosteroids versus corticosteroid monotherapy.</p></li>
</ol></section><section id="CD016094-sec3-0016"><h4 class="pmc_sec_title">Investigation of heterogeneity and subgroup analysis</h4>
<p>Clinical and methodological diversity will be assessed in terms of participants, interventions, outcomes and study characteristics for the included studies to determine whether a meta‐analysis is appropriate. This will be conducted by observing the data from the data extraction tables. Statistical heterogeneity will be assessed by visual inspection of the forest plot to assess for obvious differences in results between the studies, and using the I<sup>2</sup> and Chi<sup>2</sup> statistical tests. As recommended in the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0030" class="usa-link" aria-describedby="CD016094-bib-0030">30</a>], the interpretation of an I<sup>2</sup> value of 0% to 40% might 'not be important'; 30% to 60% may represent 'moderate' heterogeneity; 50% to 90% may represent 'substantial' heterogeneity; and 75% to 100% represents 'considerable' heterogeneity. As noted in the <em>Cochrane Handbook for Systematic Reviews of Interventions</em>, we will keep in mind that the importance of I<sup>2</sup> depends on: (i) magnitude and direction of effects and (ii) strength of evidence for heterogeneity. The Chi<sup>2</sup> test will be interpreted where a P value &lt; 0.10 will indicate evidence of statistical heterogeneity. If we identify substantial heterogeneity, we will report it and investigate possible causes by following the recommendations in Chapter 10, Section 10 of the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0063" class="usa-link" aria-describedby="CD016094-bib-0063">63</a>]<em>.</em></p>
<p>Since the mechanisms of action of the different drugs within the main intervention groups (biologics and csDMARDs) may vary significantly (e.g. abatacept versus rituximab; methotrexate versus mycophenolate mofetil), we will perform subgroup analyses to investigate the effects of different mechanisms of action, or individual drugs, within these groups, compared to corticosteroid monotherapy. Subgroups may include, for example, B‐cell depleting therapies, IL‐6 inhibitors, purine and pyrimidine synthesis inhibitors, folate metabolism inhibitors, and alkylating agents.</p>
<p>Including trials investigating single‐organ disease and multi‐organ disease in the same analysis could introduce heterogeneity due to potential differences in prognosis and treatment response. Therefore, we will consider performing a subgroup analysis, stratifying studies with more than 50% of participants with single‐organ disease versus studies with more than 50% of participants with multi‐organ disease, should the primary analysis reveal significant heterogeneity.</p>
<p>The outcomes of choice for subgroup analyses will be disease flares and withdrawals due to adverse events.</p>
<p>We will use the formal test for subgroup interactions in Review Manager [<a href="#CD016094-bib-0054" class="usa-link" aria-describedby="CD016094-bib-0054">54</a>] and will use caution in the interpretation of subgroup analysis as advised in Chapter 10 of the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0063" class="usa-link" aria-describedby="CD016094-bib-0063">63</a>]. The magnitude of the effects will be compared between the subgroups by means of assessing the overlap of the CIs with the summary estimate. Non‐overlap of the CIs indicates statistical significance.</p>
<section id="CD016094-sec4-0005"><h5 class="pmc_sec_title">Equity‐related assessment</h5>
<p>IgG4‐related disease is a relatively newly recognised condition, and most current research efforts are focused on understanding its clinical features and evaluating core treatment strategies. As such, equity‐related variables (such as ethnicity, socioeconomic status, religion, or sexual orientation) are typically not collected or reported in published studies. Therefore, we believe it is premature to systematically assess equity issues in this context. Furthermore, a meaningful equity‐focused assessment would require an individual participant data systematic review, which is beyond the scope of our work. Nevertheless, we acknowledge that IgG4‐related disease predominantly affects older adults, a population that may be considered vulnerable and, where possible, we will consider age‐related implications in our interpretation of the findings.</p></section></section><section id="CD016094-sec3-0017"><h4 class="pmc_sec_title">Sensitivity analysis</h4>
<p>To explore the robustness of our findings, we will perform a sensitivity analysis for the outcome disease flares by excluding studies at overall high RoB. We will also perform a sensitivity analysis using a fixed‐effect model, including all the studies.</p>
<p>Sensitivity analyses reported above will only be performed for the comparison of biologic monotherapy or combined with corticosteroids versus corticosteroid monotherapy.</p>
<p>The primary analysis will include outcomes that are assessed at the latest available time point in each study. This method aims to maximise statistical power. However, it may generate biased estimates for time‐dependent outcomes (e.g. disease remission), especially if the time points are very different between the studies. Therefore, we will perform a sensitivity analysis stratified by study duration (≤ 6 months versus &gt; 6 months), but only if the primary analysis reveals substantial heterogeneity for disease remission that cannot be attributed to other factors (e.g. differences in treatment). The outcome disease flares is a time‐to‐event outcome, and it should not be affected, provided the assumption of proportional hazard is fulfilled. Therefore, we will assess the plausibility of the proportional hazards assumption by examining the Kaplan–Meier curves reported in the included studies, where available. If the curves show approximately proportional separation over time, we will consider the assumption reasonable. If substantial violations are suspected, we will conduct a sensitivity analysis excluding those studies.</p>
<p>These sensitivity analyses will be performed for all the comparisons.</p></section><section id="CD016094-sec3-0018"><h4 class="pmc_sec_title">Certainty of the evidence assessment</h4>
<p>We will create summary of findings tables using the following outcomes.</p>
<ul class="list" style="list-style-type:disc">
<li><p>Disease flares</p></li>
<li><p>Disease response</p></li>
<li><p>HRQoL</p></li>
<li><p>Withdrawal due to adverse events</p></li>
<li><p>Serious adverse events.</p></li>
</ul>
<p>Time points of interest will be within a medium‐ to long‐term time frame (e.g. up to 12 months). Details are specified in the section <a href="#CD016094-sec2-0005" class="usa-link">Outcome measures</a> and <a href="#CD016094-sec3-0015" class="usa-link">Synthesis methods</a>.</p>
<p>Key comparisons of interest will be:</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Biologics versus corticosteroid monotherapy</p></li>
<li><p>csDMARDs versus corticosteroid monotherapy.</p></li>
</ol>
<p>Two review authors (GC, MB) will independently assess the certainty of the evidence. We will resolve disagreements by consensus or by involving a third review author (AB). We will use the five GRADE (Grades of Recommendation, Assessment, Development and Evaluation) considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the certainty of a body of evidence as it relates to the studies which contribute data to the meta‐analyses for the prespecified outcomes, and report the certainty of evidence as high, moderate, low, or very low [<a href="#CD016094-bib-0064" class="usa-link" aria-describedby="CD016094-bib-0064">64</a>].</p>
<ul class="list" style="list-style-type:disc">
<li><p>High: we are very confident that the true effect lies close to that of the estimate of the effect.</p></li>
<li><p>Moderate: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.</p></li>
<li><p>Low: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.</p></li>
<li><p>Very low: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.</p></li>
</ul>
<p>We will use the methods and recommendations described in Chapter 14 of the <em>Cochrane Handbook for Systematic Reviews of Interventions</em> [<a href="#CD016094-bib-0065" class="usa-link" aria-describedby="CD016094-bib-0065">65</a>]. We will use GRADEpro software to prepare the summary of findings tables [<a href="#CD016094-bib-0058" class="usa-link" aria-describedby="CD016094-bib-0058">58</a>]. We will justify all decisions to downgrade the certainty of studies using footnotes, and we will make comments to aid the reader's understanding of the review where necessary. We will provide absolute and relative percentage change in the 'Comments' column of the summary of findings tables, as described in <a href="#CD016094-sec3-0011" class="usa-link">Measures of treatment effect</a>.</p></section></section><section id="CD016094-sec2-0008"><h3 class="pmc_sec_title">Consumer involvement</h3>
<p>When developing this protocol, we collaborated with Mr Lars Boustedt, who is a person living with IgG4‐related disease, and who has been followed up at Skåne University Hospital in Lund, Sweden, since 2012. We will contact him again during review development for further feedback on the review findings and conclusions.</p></section></section><section id="sec42"><h2 class="pmc_sec_title">Supporting Information</h2>
<p>Supplementary materials are available with the online version of this article: 10.1002/14651858.CD016094.</p>
<p>Supplementary materials are published alongside the article and contain additional data and information that support or enhance the article. Supplementary materials may not be subject to the same editorial scrutiny as the content of the article and Cochrane has not copyedited, typeset or proofread these materials. The material in these sections has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</p>
<section class="sm xbox font-sm" id="CD016094-supitem-0001"><div class="caption p"><p><strong>Supplementary material 1</strong> Search strategies</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12368947/bin/CD016094-SUP-01-searchStrategy.html" data-ga-action="click_feat_suppl" class="usa-link">CD016094-SUP-01-searchStrategy.html</a><sup> (30.2KB, html) </sup>
</div></div></section></section><section id="notes1"><p>New</p></section><section id="CD016094-sec1-0004"><h2 class="pmc_sec_title">Additional information</h2>
<section id="CD016094-sec2-0009" class="ack"><h3 class="pmc_sec_title">Acknowledgements</h3>
<p>We acknowledge Matthias Bank and Maria Björklund, Library and ICT services, Lund University, Sweden, for defining the search strategies (see <a href="#CD016094-supitem-0001" class="usa-link">Supplementary material 1</a>). We thank Mr Lars Boustedt (Lund, Sweden) for his comments on the protocol as a patient living with IgG4‐related disease.</p>
<section id="CD016094-sec3-0019"><h4 class="pmc_sec_title">Editorial and peer‐reviewer contributions</h4>
<p>Cochrane Neonatal supported the authors in the development of this protocol.</p>
<p>The following people conducted the editorial process for this protocol:</p>
<ul class="list" style="list-style-type:disc">
<li><p>Sign‐off Editor (final editorial decision): Toby Lasserson, Acting Editor in Chief of The Cochrane Library;</p></li>
<li><p>Managing Editor (selected peer reviewers, provided editorial guidance to authors, edited the article): Alan Thomas, Cochrane Central Editorial Service;</p></li>
<li><p>Editorial Assistant (conducted editorial policy checks, collated peer‐reviewer comments and supported editorial team): Lisa Wydrzynski, Cochrane Central Editorial Service;</p></li>
<li><p>Copy Editor (copy editing and production): Narelle Willis, Cochrane Central Production Service;</p></li>
<li><p>Peer‐reviewers (provided comments and recommended an editorial decision): Ichiro Mizushima, Department of Nephrology and Rheumatology, Kanazawa University Hospital (clinical/content review), Guy Katz, Massachusetts General Hospital, Harvard Medical School (clinical/content review), Brian Duncan (consumer review), Clare Miles, Cochrane Evidence Production and Methods Directorate (methods review), Jo Platt, Cochrane Evidence Production and Methods Directorate (search review). One additional peer reviewer provided clinical peer review but chose not to be publicly acknowledged.</p></li>
</ul></section></section><section id="CD016094-sec2-0010"><h3 class="pmc_sec_title">Contributions of authors</h3>
<p>GC conceived, designed and wrote the protocol. RB, AB and MB critically reviewed and discussed the protocol with GC. All authors approved the final version to be published.</p></section><section id="CD016094-sec2-0011"><h3 class="pmc_sec_title">Declarations of interest</h3>
<p>GC: Alfasigma S.p.A. (Grant/Contract); payment made to home institution with no financial benefits from this payment and did not have access to or control of the funds; works as Senior Consultant Rheumatologist, Skåne University Hospital Malmö, Sweden.</p>
<p>MB: no relevant interests; Senior Editor of Cochrane Neonatal and was not involved in the editorial process or decision‐making of this protocol.</p>
<p>RB: no relevant interests; works as a general physician (AT‐läkare) in Helsingborg.</p>
<p>AB: none known.</p></section><section id="CD016094-sec2-0012"><h3 class="pmc_sec_title">Sources of support</h3>
<section id="CD016094-sec3-0020"><h4 class="pmc_sec_title">Internal sources</h4>
<ul class="list" style="list-style-type:disc"><li>
<p>Institute for Clinical Sciences, Lund University, Lund, Sweden</p>
<p>MB is employed by this organization.</p>
</li></ul></section><section id="CD016094-sec3-0021"><h4 class="pmc_sec_title">External sources</h4>
<ul class="list" style="list-style-type:disc"><li>
<p>Region Skåne, Skåne University Hospital and Lund University, Sweden</p>
<p>Cochrane Sweden is supported from Region Skåne, Skåne University Hospital and Lund University</p>
</li></ul></section></section><section id="CD016094-sec2-0013"><h3 class="pmc_sec_title">Registration and protocol</h3>
<p>Cochrane approved the proposal for this review in December 2023.</p></section><section id="CD016094-sec2-0014"><h3 class="pmc_sec_title">Data, code and other materials</h3>
<p>Data sharing is not applicable to this article as it is a protocol, so no datasets were generated or analysed.</p></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CD016094-bib-0001">
<span class="label">1.</span><cite>Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatology 2012;22(1):1-14. [DOI: 10.1007/s10165-011-0508-6]</cite> [<a href="https://doi.org/10.1007/s10165-011-0508-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3278618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21881964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Modern%20Rheumatology&amp;title=A%20novel%20clinical%20entity,%20IgG4-related%20disease%20(IgG4RD):%20general%20concept%20and%20details&amp;author=H%20Umehara&amp;author=K%20Okazaki&amp;author=Y%20Masaki&amp;author=M%20Kawano&amp;author=M%20Yamamoto&amp;volume=22&amp;issue=1&amp;publication_year=2012&amp;pages=1-14&amp;pmid=21881964&amp;doi=10.1007/s10165-011-0508-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0002">
<span class="label">2.</span><cite>Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 2015;385(9976):1460-71. [DOI: 10.1016/S0140-6736(14)60720-0]</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)60720-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25481618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=IgG4-related%20disease&amp;author=T%20Kamisawa&amp;author=Y%20Zen&amp;author=S%20Pillai&amp;author=JH%20Stone&amp;volume=385&amp;issue=9976&amp;publication_year=2015&amp;pages=1460-71&amp;pmid=25481618&amp;doi=10.1016/S0140-6736(14)60720-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0003">
<span class="label">3.</span><cite>Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis &amp; Rheumatology 2015;67(7):1688-99. [DOI: 10.1002/art.39132]</cite> [<a href="https://doi.org/10.1002/art.39132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25809420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20&amp;%20Rheumatology&amp;title=International%20consensus%20guidance%20statement%20on%20the%20management%20and%20treatment%20of%20IgG4-related%20disease&amp;author=A%20Khosroshahi&amp;author=ZS%20Wallace&amp;author=JL%20Crowe&amp;author=T%20Akamizu&amp;author=A%20Azumi&amp;volume=67&amp;issue=7&amp;publication_year=2015&amp;pages=1688-99&amp;pmid=25809420&amp;doi=10.1002/art.39132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0004">
<span class="label">4.</span><cite>Stone JH, Zen Y, Deshpande V. IgG4-related disease. New England Journal of Medicine 2012;366(6):539-51. [DOI: 10.1056/NEJMra1104650]</cite> [<a href="https://doi.org/10.1056/NEJMra1104650" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22316447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=IgG4-related%20disease&amp;author=JH%20Stone&amp;author=Y%20Zen&amp;author=V%20Deshpande&amp;volume=366&amp;issue=6&amp;publication_year=2012&amp;pages=539-51&amp;pmid=22316447&amp;doi=10.1056/NEJMra1104650&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0005">
<span class="label">5.</span><cite>Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nature Reviews Rheumatology 2020;16(12):702-14. [DOI: 10.1038/s41584-020-0500-7]</cite> [<a href="https://doi.org/10.1038/s41584-020-0500-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32939060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Rheumatology&amp;title=IgG4-related%20disease:%20an%20update%20on%20pathophysiology%20and%20implications%20for%20clinical%20care&amp;author=CA%20Perugino&amp;author=JH%20Stone&amp;volume=16&amp;issue=12&amp;publication_year=2020&amp;pages=702-14&amp;pmid=32939060&amp;doi=10.1038/s41584-020-0500-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0006">
<span class="label">6.</span><cite>Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis &amp; Rheumatology 2020;72(1):7-19. [DOI: 10.1002/art.41120]</cite> [<a href="https://doi.org/10.1002/art.41120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31793250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20&amp;%20Rheumatology&amp;title=The%202019%20American%20College%20of%20Rheumatology/European%20League%20Against%20Rheumatism%20classification%20criteria%20for%20IgG4-related%20disease&amp;author=ZS%20Wallace&amp;author=RP%20Naden&amp;author=S%20Chari&amp;author=H%20Choi&amp;author=E%20Della-Torre&amp;volume=72&amp;issue=1&amp;publication_year=2020&amp;pages=7-19&amp;pmid=31793250&amp;doi=10.1002/art.41120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0007">
<span class="label">7.</span><cite>Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathology 2012;25(9):1181-92. [DOI: 10.1038/modpathol.2012.72]</cite> [<a href="https://doi.org/10.1038/modpathol.2012.72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22596100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Modern%20Pathology&amp;title=Consensus%20statement%20on%20the%20pathology%20of%20IgG4-related%20disease&amp;author=V%20Deshpande&amp;author=Y%20Zen&amp;author=JK%20Chan&amp;author=EE%20Yi&amp;author=Y%20Sato&amp;volume=25&amp;issue=9&amp;publication_year=2012&amp;pages=1181-92&amp;pmid=22596100&amp;doi=10.1038/modpathol.2012.72&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0008">
<span class="label">8.</span><cite>Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine 2015;94(15):e680. [DOI: 10.1097/MD.0000000000000680]</cite> [<a href="https://doi.org/10.1097/MD.0000000000000680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4602507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25881845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine&amp;title=IgG4-related%20disease:%20dataset%20of%20235%20consecutive%20patients&amp;author=D%20Inoue&amp;author=K%20Yoshida&amp;author=N%20Yoneda&amp;author=K%20Ozaki&amp;author=T%20Matsubara&amp;volume=94&amp;issue=15&amp;publication_year=2015&amp;pages=e680&amp;pmid=25881845&amp;doi=10.1097/MD.0000000000000680&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0009">
<span class="label">9.</span><cite>Kamisawa T, Okazaki K. Diagnosis and treatment of IgG4-related disease. Current Topics in Microbiology &amp; Immunology 2017;401:19-33. [DOI: 10.1007/82_2016_36]</cite> [<a href="https://doi.org/10.1007/82_2016_36" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28197739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Topics%20in%20Microbiology%20&amp;%20Immunology&amp;title=Diagnosis%20and%20treatment%20of%20IgG4-related%20disease&amp;author=T%20Kamisawa&amp;author=K%20Okazaki&amp;volume=401&amp;publication_year=2017&amp;pages=19-33&amp;pmid=28197739&amp;doi=10.1007/82_2016_36&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0010">
<span class="label">10.</span><cite>Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. American Journal of Gastroenterology 2009;104(9):2295-306. [DOI: 10.1038/ajg.2009.325]</cite> [<a href="https://doi.org/10.1038/ajg.2009.325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6583795/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19532132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Gastroenterology&amp;title=Evaluation%20and%20management%20of%20autoimmune%20pancreatitis:%20experience%20at%20a%20large%20US%20center&amp;author=A%20Raina&amp;author=D%20Yadav&amp;author=AM%20Krasinskas&amp;author=KM%20McGrath&amp;author=A%20Khalid&amp;volume=104&amp;issue=9&amp;publication_year=2009&amp;pages=2295-306&amp;pmid=19532132&amp;doi=10.1038/ajg.2009.325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0011">
<span class="label">11.</span><cite>Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. [DOI: 10.1136/bmj.m1067]</cite> [<a href="https://doi.org/10.1136/bmj.m1067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32546500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Advances%20in%20the%20diagnosis%20and%20management%20of%20IgG4%20related%20disease&amp;author=M%20Lanzillotta&amp;author=G%20Mancuso&amp;author=E%20Della-Torre&amp;volume=369&amp;publication_year=2020&amp;pages=m1067&amp;pmid=32546500&amp;doi=10.1136/bmj.m1067&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0012">
<span class="label">12.</span><cite>Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. International Journal of Rheumatology 2012;2012:358371. [DOI: 10.1155/2012/358371]</cite> [<a href="https://doi.org/10.1155/2012/358371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3415093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22899936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Rheumatology&amp;title=Prevalence%20of%20IgG4-related%20disease%20in%20Japan%20based%20on%20nationwide%20survey%20in%202009&amp;author=K%20Uchida&amp;author=A%20Masamune&amp;author=T%20Shimosegawa&amp;author=K%20Okazaki&amp;volume=2012&amp;publication_year=2012&amp;pages=358371&amp;pmid=22899936&amp;doi=10.1155/2012/358371&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0013">
<span class="label">13.</span><cite>Wallace ZS, Miles G, Smolkina E, Petruski-Ivleva N, Madziva D, Cook C, et al. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Annals of the Rheumatic Diseases 2023;82(7):957-62. [DOI: 10.1136/ard-2023-223950]</cite> [<a href="https://doi.org/10.1136/ard-2023-223950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37137671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20Rheumatic%20Diseases&amp;title=Incidence,%20prevalence%20and%20mortality%20of%20IgG4-related%20disease%20in%20the%20USA:%20a%20claims-based%20analysis%20of%20commercially%20insured%20adults&amp;author=ZS%20Wallace&amp;author=G%20Miles&amp;author=E%20Smolkina&amp;author=N%20Petruski-Ivleva&amp;author=D%20Madziva&amp;volume=82&amp;issue=7&amp;publication_year=2023&amp;pages=957-62&amp;pmid=37137671&amp;doi=10.1136/ard-2023-223950&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0014">
<span class="label">14.</span><cite>Jha I, McMahon GA, Perugino CA, Katz G, Wallace ZS, Fernandes A, et al. Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of 328 patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria. 2024 Lancet Rheumatology;6(7):e460-8. [DOI: 10.1016/S2665-9913(24)00089-4]</cite> [<a href="https://doi.org/10.1016/S2665-9913(24)00089-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11214762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38824935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=2024&amp;title=Sex%20as%20a%20predictor%20of%20clinical%20phenotype%20and%20determinant%20of%20immune%20response%20in%20IgG4-related%20disease:%20a%20retrospective%20study%20of%20328%20patients%20fulfilling%20the%20American%20College%20of%20Rheumatology-European%20League%20Against%20Rheumatism%20classification%20criteria&amp;author=I%20Jha&amp;author=GA%20McMahon&amp;author=CA%20Perugino&amp;author=G%20Katz&amp;author=ZS%20Wallace&amp;volume=6&amp;issue=7&amp;pages=e460-8&amp;pmid=38824935&amp;doi=10.1016/S2665-9913(24)00089-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0015">
<span class="label">15.</span><cite>Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis &amp; Rheumatology 2015;67(9):2466-75. [DOI: 10.1002/art.39205]</cite> [<a href="https://doi.org/10.1002/art.39205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4621270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25988916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20&amp;%20Rheumatology&amp;title=IgG4-related%20disease:%20clinical%20and%20laboratory%20features%20in%20one%20hundred%20twenty-five%20patients&amp;author=ZS%20Wallace&amp;author=V%20Deshpande&amp;author=H%20Mattoo&amp;author=VS%20Mahajan&amp;author=M%20Kulikova&amp;volume=67&amp;issue=9&amp;publication_year=2015&amp;pages=2466-75&amp;pmid=25988916&amp;doi=10.1002/art.39205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0016">
<span class="label">16.</span><cite>Wang L, Zhang P, Zhang X, Lin W, Tang H, Li J, et al. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients. Rheumatology 2019;58:820-30. [DOI: 10.1093/rheumatology/key397]</cite> [<a href="https://doi.org/10.1093/rheumatology/key397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30561747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology&amp;title=Sex%20disparities%20in%20clinical%20characteristics%20and%20prognosis%20of%20immunoglobulin%20G4-related%20disease:%20a%20prospective%20study%20of%20403%20patients&amp;author=L%20Wang&amp;author=P%20Zhang&amp;author=X%20Zhang&amp;author=W%20Lin&amp;author=H%20Tang&amp;volume=58&amp;publication_year=2019&amp;pages=820-30&amp;pmid=30561747&amp;doi=10.1093/rheumatology/key397&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0017">
<span class="label">17.</span><cite>Stone JH. IgG4-related disease: lessons from the first 20 years. Rheumatology 2025;64(Suppl 1):i24-7. [DOI: 10.1093/rheumatology/keaf008]</cite> [<a href="https://doi.org/10.1093/rheumatology/keaf008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40071397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology&amp;title=IgG4-related%20disease:%20lessons%20from%20the%20first%2020%20years&amp;author=JH%20Stone&amp;volume=64&amp;issue=Suppl%201&amp;publication_year=2025&amp;pages=i24-7&amp;pmid=40071397&amp;doi=10.1093/rheumatology/keaf008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0018">
<span class="label">18.</span><cite>Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. Journal of Allergy &amp; Clinical Immunology 2014;134(3):679-87. [DOI: 10.1016/j.jaci.2014.03.034]</cite> [<a href="https://doi.org/10.1016/j.jaci.2014.03.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4149918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24815737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Allergy%20&amp;%20Clinical%20Immunology&amp;title=De%20novo%20oligoclonal%20expansions%20of%20circulating%20plasmablasts%20in%20active%20and%20relapsing%20IgG4-related%20disease&amp;author=H%20Mattoo&amp;author=VS%20Mahajan&amp;author=E%20Della-Torre&amp;author=Y%20Sekigami&amp;author=M%20Carruthers&amp;volume=134&amp;issue=3&amp;publication_year=2014&amp;pages=679-87&amp;pmid=24815737&amp;doi=10.1016/j.jaci.2014.03.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0019">
<span class="label">19.</span><cite>Maehara T, Mattoo H, Ohta M, Mahajan VS, Moriyama M, Yamauchi M, et al. Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Annals of the Rheumatic Diseases 2017;76(2):377-85. [DOI: 10.1136/annrheumdis-2016-209139]</cite> [<a href="https://doi.org/10.1136/annrheumdis-2016-209139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5435236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27358392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20Rheumatic%20Diseases&amp;title=Lesional%20CD4+%20IFN-%CE%B3+%20cytotoxic%20T%20lymphocytes%20in%20IgG4-related%20dacryoadenitis%20and%20sialoadenitis&amp;author=T%20Maehara&amp;author=H%20Mattoo&amp;author=M%20Ohta&amp;author=VS%20Mahajan&amp;author=M%20Moriyama&amp;volume=76&amp;issue=2&amp;publication_year=2017&amp;pages=377-85&amp;pmid=27358392&amp;doi=10.1136/annrheumdis-2016-209139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0020">
<span class="label">20.</span><cite>Hubers LM, Vos H, Schuurman AR, Erken R, Oude Elferink RP, Burgering B, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut 2018;67(4):728-35. [DOI: 10.1136/gutjnl-2017-314548]</cite> [<a href="https://doi.org/10.1136/gutjnl-2017-314548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28765476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Annexin%20A11%20is%20targeted%20by%20IgG4%20and%20IgG1%20autoantibodies%20in%20IgG4-related%20disease&amp;author=LM%20Hubers&amp;author=H%20Vos&amp;author=AR%20Schuurman&amp;author=R%20Erken&amp;author=RP%20Oude%20Elferink&amp;volume=67&amp;issue=4&amp;publication_year=2018&amp;pages=728-35&amp;pmid=28765476&amp;doi=10.1136/gutjnl-2017-314548&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0021">
<span class="label">21.</span><cite>Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Clinical Immunology 2015;156(1):9-18. [DOI: 10.1016/j.clim.2014.10.008]</cite> [<a href="https://doi.org/10.1016/j.clim.2014.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25450336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Immunology&amp;title=Preferential%20M2%20macrophages%20contribute%20to%20fibrosis%20in%20IgG4-related%20dacryoadenitis%20and%20sialoadenitis,%20so-called%20Mikulicz's%20disease&amp;author=S%20Furukawa&amp;author=M%20Moriyama&amp;author=A%20Tanaka&amp;author=T%20Maehara&amp;author=H%20Tsuboi&amp;volume=156&amp;issue=1&amp;publication_year=2015&amp;pages=9-18&amp;pmid=25450336&amp;doi=10.1016/j.clim.2014.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0022">
<span class="label">22.</span><cite>Akiyama M, Suzuki K, Yamaoka K, Yasuoka H, Takeshita M, Kaneko Y, et al. Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease. Arthritis &amp; Rheumatology 2015;67(9):2476-81. [DOI: 10.1002/art.39209]</cite> [<a href="https://doi.org/10.1002/art.39209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25989153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20&amp;%20Rheumatology&amp;title=Number%20of%20circulating%20follicular%20helper%202%20T%20cells%20correlates%20with%20IgG4%20and%20interleukin-4%20levels%20and%20plasmablast%20numbers%20in%20IgG4-related%20disease&amp;author=M%20Akiyama&amp;author=K%20Suzuki&amp;author=K%20Yamaoka&amp;author=H%20Yasuoka&amp;author=M%20Takeshita&amp;volume=67&amp;issue=9&amp;publication_year=2015&amp;pages=2476-81&amp;pmid=25989153&amp;doi=10.1002/art.39209&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0023">
<span class="label">23.</span><cite>Bilal J, Berlinberg A, Riaz IB, Faridi W, Bhattacharjee S, Ortega G, et al. Risk of infections and cancer in patients with rheumatologic diseases receiving interleukin inhibitors: a systematic review and meta-analysis [Erratum in: JAMA Netw Open. 2020 Apr 1;3(4):e205507. doi: 10.1001/jamanetworkopen.2020.5507]. JAMA Network Open 2019;2(10):e1913102. [DOI: 10.1001/jamanetworkopen.2019.13102]</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2019.13102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6813598/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31626313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Network%20Open&amp;title=Risk%20of%20infections%20and%20cancer%20in%20patients%20with%20rheumatologic%20diseases%20receiving%20interleukin%20inhibitors:%20a%20systematic%20review%20and%20meta-analysis%20%5BErratum%20in:%20JAMA%20Netw%20Open.%202020%20Apr%201;3(4):e205507.%20doi:%2010.1001/jamanetworkopen.2020.5507%5D&amp;author=J%20Bilal&amp;author=A%20Berlinberg&amp;author=IB%20Riaz&amp;author=W%20Faridi&amp;author=S%20Bhattacharjee&amp;volume=2&amp;issue=10&amp;publication_year=2019&amp;pages=e1913102&amp;pmid=31626313&amp;doi=10.1001/jamanetworkopen.2019.13102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0024">
<span class="label">24.</span><cite>Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295(19):2275-85. [DOI: 10.1001/jama.295.19.2275]</cite> [<a href="https://doi.org/10.1001/jama.295.19.2275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16705109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Anti-TNF%20antibody%20therapy%20in%20rheumatoid%20arthritis%20and%20the%20risk%20of%20serious%20infections%20and%20malignancies:%20systematic%20review%20and%20meta-analysis%20of%20rare%20harmful%20effects%20in%20randomized%20controlled%20trials&amp;author=T%20Bongartz&amp;author=AJ%20Sutton&amp;author=MJ%20Sweeting&amp;author=I%20Buchan&amp;author=EL%20Matteson&amp;volume=295&amp;issue=19&amp;publication_year=2006&amp;pages=2275-85&amp;pmid=16705109&amp;doi=10.1001/jama.295.19.2275&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0025">
<span class="label">25.</span><cite>Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis &amp; Rheumatism 2010;62(9):2625-32. [DOI: 10.1002/art.27555]</cite> [<a href="https://doi.org/10.1002/art.27555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20506353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20&amp;%20Rheumatism&amp;title=Risk%20factors%20for%20severe%20infections%20in%20patients%20with%20rheumatoid%20arthritis%20treated%20with%20rituximab%20in%20the%20autoimmunity%20and%20rituximab%20registry&amp;author=JE%20Gottenberg&amp;author=P%20Ravaud&amp;author=T%20Bardin&amp;author=P%20Cacoub&amp;author=A%20Cantagrel&amp;volume=62&amp;issue=9&amp;publication_year=2010&amp;pages=2625-32&amp;pmid=20506353&amp;doi=10.1002/art.27555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0026">
<span class="label">26.</span><cite>Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PloS ONE [Electronic Resource] 2017;12(9):e0183844. [DOI: 10.1371/journal.pone.0183844]</cite> [<a href="https://doi.org/10.1371/journal.pone.0183844" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5600376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28915275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PloS%20ONE%20%5BElectronic%20Resource%5D&amp;title=Long-term%20efficacy%20and%20safety%20of%20rituximab%20in%20IgG4-related%20disease:%20data%20from%20a%20French%20nationwide%20study%20of%20thirty-three%20patients&amp;author=M%20Ebbo&amp;author=A%20Grados&amp;author=M%20Samson&amp;author=M%20Groh&amp;author=A%20Loundou&amp;volume=12&amp;issue=9&amp;publication_year=2017&amp;pages=e0183844&amp;pmid=28915275&amp;doi=10.1371/journal.pone.0183844&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0027">
<span class="label">27.</span><cite>Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. Journal of Gastroenterology 2003;38(10):982-4. [DOI: 10.1007/s00535-003-1175-y]</cite> [<a href="https://doi.org/10.1007/s00535-003-1175-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14614606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Gastroenterology&amp;title=A%20new%20clinicopathological%20entity%20of%20IgG4-related%20autoimmune%20disease&amp;author=T%20Kamisawa&amp;author=N%20Funata&amp;author=Y%20Hayashi&amp;author=Y%20Eishi&amp;author=M%20Koike&amp;volume=38&amp;issue=10&amp;publication_year=2003&amp;pages=982-4&amp;pmid=14614606&amp;doi=10.1007/s00535-003-1175-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0028">
<span class="label">28.</span><cite>Masaki Y, Shimizu H, Sato Nakamura T, Nakamura T, Nakajima A, Iwao Kawanami H, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. Journal of Clinical &amp; Experimental Hematopathology 2014;54(2):95-101. [DOI: 10.3960/jslrt.54.95]</cite> [<a href="https://doi.org/10.3960/jslrt.54.95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25318941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20&amp;%20Experimental%20Hematopathology&amp;title=IgG4-related%20disease:%20diagnostic%20methods%20and%20therapeutic%20strategies%20in%20Japan&amp;author=Y%20Masaki&amp;author=H%20Shimizu&amp;author=T%20Sato%20Nakamura&amp;author=T%20Nakamura&amp;author=A%20Nakajima&amp;volume=54&amp;issue=2&amp;publication_year=2014&amp;pages=95-101&amp;pmid=25318941&amp;doi=10.3960/jslrt.54.95&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0029">
<span class="label">29.</span><cite>Omar D, Chen Y, Cong Y, Dong L. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis. Rheumatology 2020;59(4):718-26. [DOI: 10.1093/rheumatology/kez380]</cite> [<a href="https://doi.org/10.1093/rheumatology/kez380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31511884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology&amp;title=Glucocorticoids%20and%20steroid%20sparing%20medications%20monotherapies%20or%20in%20combination%20for%20IgG4-RD:%20a%20systematic%20review%20and%20network%20meta-analysis&amp;author=D%20Omar&amp;author=Y%20Chen&amp;author=Y%20Cong&amp;author=L%20Dong&amp;volume=59&amp;issue=4&amp;publication_year=2020&amp;pages=718-26&amp;pmid=31511884&amp;doi=10.1093/rheumatology/kez380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0030">
<span class="label">30.</span><cite>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite> [<a href="https://doi.org/10.1002/14651858.ED000142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10284251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31643080/" class="usa-link">PubMed</a>]</li>
<li id="CD016094-bib-0031">
<span class="label">31.</span><cite>Higgins JP, Lasserson T, Thomas J, Flemyng E, Churchill R. Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023. Available from https://community.cochrane.org/mecir-manual 2023.</cite>
</li>
<li id="CD016094-bib-0032">
<span class="label">32.</span><cite>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. [DOI: 10.1136/bmj.n71]</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=The%20PRISMA%202020%20statement:%20an%20updated%20guideline%20for%20reporting%20systematic%20reviews&amp;author=MJ%20Page&amp;author=JE%20McKenzie&amp;author=PM%20Bossuyt&amp;author=I%20Boutron&amp;author=TC%20Hoffmann&amp;volume=372&amp;publication_year=2021&amp;pages=n71&amp;pmid=33782057&amp;doi=10.1136/bmj.n71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0033">
<span class="label">33.</span><cite>Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160. [DOI: 10.1136/bmj.n160]</cite> [<a href="https://doi.org/10.1136/bmj.n160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33781993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=PRISMA%202020%20explanation%20and%20elaboration:%20updated%20guidance%20and%20exemplars%20for%20reporting%20systematic%20reviews&amp;author=MJ%20Page&amp;author=D%20Moher&amp;author=PM%20Bossuyt&amp;author=I%20Boutron&amp;author=TC%20Hoffmann&amp;volume=372&amp;publication_year=2021&amp;pages=n160&amp;pmid=33781993&amp;doi=10.1136/bmj.n160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0034">
<span class="label">34.</span><cite>Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Modern Rheumatology 2012;22(1):21-30. [DOI: 10.1007/s10165-011-0571-z]</cite> [<a href="https://doi.org/10.1007/s10165-011-0571-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22218969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Modern%20Rheumatology&amp;title=Comprehensive%20diagnostic%20criteria%20for%20IgG4-related%20disease%20(IgG4-RD),%202011&amp;author=H%20Umehara&amp;author=K%20Okazaki&amp;author=Y%20Masaki&amp;author=M%20Kawano&amp;author=M%20Yamamoto&amp;volume=22&amp;issue=1&amp;publication_year=2012&amp;pages=21-30&amp;pmid=22218969&amp;doi=10.1007/s10165-011-0571-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0035">
<span class="label">35.</span><cite>Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Modern Rheumatology 2021;31(3):529-33. [DOI: 10.1080/14397595.2020.1859710]</cite> [<a href="https://doi.org/10.1080/14397595.2020.1859710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33274670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Modern%20Rheumatology&amp;title=The%202020%20revised%20comprehensive%20diagnostic%20(RCD)%20criteria%20for%20IgG4-RD&amp;author=H%20Umehara&amp;author=K%20Okazaki&amp;author=S%20Kawa&amp;author=H%20Takahashi&amp;author=H%20Goto&amp;volume=31&amp;issue=3&amp;publication_year=2021&amp;pages=529-33&amp;pmid=33274670&amp;doi=10.1080/14397595.2020.1859710&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0036">
<span class="label">36.</span><cite>Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40(3):352-8. [DOI: 10.1097/MPA.0b013e3182142fd2]</cite> [<a href="https://doi.org/10.1097/MPA.0b013e3182142fd2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21412117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pancreas&amp;title=International%20consensus%20diagnostic%20criteria%20for%20autoimmune%20pancreatitis:%20guidelines%20of%20the%20International%20Association%20of%20Pancreatology&amp;author=T%20Shimosegawa&amp;author=ST%20Chari&amp;author=L%20Frulloni&amp;author=T%20Kamisawa&amp;author=S%20Kawa&amp;volume=40&amp;issue=3&amp;publication_year=2011&amp;pages=352-8&amp;pmid=21412117&amp;doi=10.1097/MPA.0b013e3182142fd2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0037">
<span class="label">37.</span><cite>Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. Journal of Rheumatology 2010;37(7):1380-5. [DOI: 10.3899/jrheum.091153]</cite> [<a href="https://doi.org/10.3899/jrheum.091153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20436071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Rheumatology&amp;title=IgG4-related%20diseases%20including%20Mikulicz's%20disease%20and%20sclerosing%20pancreatitis:%20diagnostic%20insights&amp;author=Y%20Masaki&amp;author=S%20Sugai&amp;author=H%20Umehara&amp;volume=37&amp;issue=7&amp;publication_year=2010&amp;pages=1380-5&amp;pmid=20436071&amp;doi=10.3899/jrheum.091153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0038">
<span class="label">38.</span><cite>Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clinical &amp; Experimental Nephrology 2011;15(5):615-26. [DOI: 10.1007/s10157-011-0521-2]</cite> [<a href="https://doi.org/10.1007/s10157-011-0521-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21898030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20&amp;%20Experimental%20Nephrology&amp;title=Proposal%20for%20diagnostic%20criteria%20for%20IgG4-related%20kidney%20disease&amp;author=M%20Kawano&amp;author=T%20Saeki&amp;author=H%20Nakashima&amp;author=S%20Nishi&amp;author=Y%20Yamaguchi&amp;volume=15&amp;issue=5&amp;publication_year=2011&amp;pages=615-26&amp;pmid=21898030&amp;doi=10.1007/s10157-011-0521-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0039">
<span class="label">39.</span><cite>Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. Journal of Hepato-Biliary-Pancreatic Sciences 2012;19(5):536-42. [DOI: 10.1007/s00534-012-0521-y]</cite> [<a href="https://doi.org/10.1007/s00534-012-0521-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22717980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepato-Biliary-Pancreatic%20Sciences&amp;title=Clinical%20diagnostic%20criteria%20of%20IgG4-related%20sclerosing%20cholangitis%202012&amp;author=H%20Ohara&amp;author=K%20Okazaki&amp;author=H%20Tsubouchi&amp;author=K%20Inui&amp;author=S%20Kawa&amp;volume=19&amp;issue=5&amp;publication_year=2012&amp;pages=536-42&amp;pmid=22717980&amp;doi=10.1007/s00534-012-0521-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0040">
<span class="label">40.</span><cite>Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease [Erratum in: Jpn J Ophthalmol. 2015 May;59(3):201. doi: 10.1007/s10384-015-0376-2]. Japanese Journal of Ophthalmology 2015;59(1):1-7. [DOI: 10.1007/s10384-014-0352-2]</cite> [<a href="https://doi.org/10.1007/s10384-014-0352-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25392273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Japanese%20Journal%20of%20Ophthalmology&amp;title=Diagnostic%20criteria%20for%20IgG4-related%20ophthalmic%20disease%20%5BErratum%20in:%20Jpn%20J%20Ophthalmol.%202015%20May;59(3):201.%20doi:%2010.1007/s10384-015-0376-2%5D&amp;author=H%20Goto&amp;author=M%20Takahira&amp;author=A%20Azumi&amp;volume=59&amp;issue=1&amp;publication_year=2015&amp;pages=1-7&amp;pmid=25392273&amp;doi=10.1007/s10384-014-0352-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0041">
<span class="label">41.</span><cite>Matsui S, Yamamoto H, Minamoto S, Waseda Y, Mishima M, Kubo K. Proposed diagnostic criteria for IgG4-related respiratory disease. Respiratory Investigation 2016;54(2):130-2. [DOI: 10.1016/j.resinv.2015.09.002]</cite> [<a href="https://doi.org/10.1016/j.resinv.2015.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26879484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respiratory%20Investigation&amp;title=Proposed%20diagnostic%20criteria%20for%20IgG4-related%20respiratory%20disease&amp;author=S%20Matsui&amp;author=H%20Yamamoto&amp;author=S%20Minamoto&amp;author=Y%20Waseda&amp;author=M%20Mishima&amp;volume=54&amp;issue=2&amp;publication_year=2016&amp;pages=130-2&amp;pmid=26879484&amp;doi=10.1016/j.resinv.2015.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0042">
<span class="label">42.</span><cite>Mizushima I, Kasashima S, Fujinaga Y, Notohara K, Saeki T, Zen Y, et al. Clinical and pathological characteristics of IgG4-related periaortitis/periarteritis and retroperitoneal fibrosis diagnosed based on experts' diagnosis. Annals of Vascular Diseases 2019;12(4):460-72. [DOI: 10.3400/avd.oa.19-00085]</cite> [<a href="https://doi.org/10.3400/avd.oa.19-00085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6957903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31942203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Vascular%20Diseases&amp;title=Clinical%20and%20pathological%20characteristics%20of%20IgG4-related%20periaortitis/periarteritis%20and%20retroperitoneal%20fibrosis%20diagnosed%20based%20on%20experts'%20diagnosis&amp;author=I%20Mizushima&amp;author=S%20Kasashima&amp;author=Y%20Fujinaga&amp;author=K%20Notohara&amp;author=T%20Saeki&amp;volume=12&amp;issue=4&amp;publication_year=2019&amp;pages=460-72&amp;pmid=31942203&amp;doi=10.3400/avd.oa.19-00085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0043">
<span class="label">43.</span><cite>Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Annals of the Rheumatic Diseases 2014;73(6):958-67. [DOI: 10.1136/annrheumdis-2013-205139]</cite> [<a href="https://doi.org/10.1136/annrheumdis-2013-205139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24739325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20Rheumatic%20Diseases&amp;title=Treat-to-target%20in%20systemic%20lupus%20erythematosus:%20recommendations%20from%20an%20international%20task%20force&amp;author=RF%20Vollenhoven&amp;author=M%20Mosca&amp;author=G%20Bertsias&amp;author=D%20Isenberg&amp;author=A%20Kuhn&amp;volume=73&amp;issue=6&amp;publication_year=2014&amp;pages=958-67&amp;pmid=24739325&amp;doi=10.1136/annrheumdis-2013-205139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0044">
<span class="label">44.</span><cite>Merkel PA, Herlyn K, Mahr AD, Neogi T, Seo P, Walsh M, et al. Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. Journal of Rheumatology 2009;36(10):2362-8. [DOI: 10.3899/jrheum.090373]</cite> [<a href="https://doi.org/10.3899/jrheum.090373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3142467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19820226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Rheumatology&amp;title=Progress%20towards%20a%20core%20set%20of%20outcome%20measures%20in%20small-vessel%20vasculitis.%20Report%20from%20OMERACT%209&amp;author=PA%20Merkel&amp;author=K%20Herlyn&amp;author=AD%20Mahr&amp;author=T%20Neogi&amp;author=P%20Seo&amp;volume=36&amp;issue=10&amp;publication_year=2009&amp;pages=2362-8&amp;pmid=19820226&amp;doi=10.3899/jrheum.090373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0045">
<span class="label">45.</span><cite>Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. Journal of Rheumatology 2011;38(7):1480-6. [DOI: 10.3899/jrheum.110276]</cite> [<a href="https://doi.org/10.3899/jrheum.110276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3645858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21724720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Rheumatology&amp;title=The%20OMERACT%20core%20set%20of%20outcome%20measures%20for%20use%20in%20clinical%20trials%20of%20ANCA-associated%20vasculitis&amp;author=PA%20Merkel&amp;author=SZ%20Aydin&amp;author=M%20Boers&amp;author=H%20Direskeneli&amp;author=K%20Herlyn&amp;volume=38&amp;issue=7&amp;publication_year=2011&amp;pages=1480-6&amp;pmid=21724720&amp;doi=10.3899/jrheum.110276&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0046">
<span class="label">46.</span><cite>Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. International Journal of Rheumatology 2012;2012:259408. [DOI: 10.1155/2012/259408]</cite> [<a href="https://doi.org/10.1155/2012/259408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3348627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22611406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Rheumatology&amp;title=Development%20of%20an%20IgG4-RD%20responder%20index&amp;author=MN%20Carruthers&amp;author=JH%20Stone&amp;author=V%20Deshpande&amp;author=A%20Khosroshahi&amp;volume=2012&amp;publication_year=2012&amp;pages=259408&amp;pmid=22611406&amp;doi=10.1155/2012/259408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0047">
<span class="label">47.</span><cite>Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, et al. An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care &amp; Research 2018;70(11):1671-8. [DOI: 10.1002/acr.23543]</cite> [<a href="https://doi.org/10.1002/acr.23543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6098740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29457382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20Care%20&amp;%20Research&amp;title=An%20international%20multispecialty%20validation%20study%20of%20the%20IgG4-related%20disease%20responder%20index&amp;author=ZS%20Wallace&amp;author=A%20Khosroshahi&amp;author=MD%20Carruthers&amp;author=CA%20Perugino&amp;author=H%20Choi&amp;volume=70&amp;issue=11&amp;publication_year=2018&amp;pages=1671-8&amp;pmid=29457382&amp;doi=10.1002/acr.23543&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0048">
<span class="label">48.</span><cite>US Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims; availability. 2009. Available from https://www.federalregister.gov/documents/2009/12/09/E9-29273/guidance-for-industry-on-patient-reported-outcome-measures-use-in-medical-product-development-to.</cite> [<a href="https://doi.org/10.1186/1477-7525-4-79" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1629006/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17034633/" class="usa-link">PubMed</a>]</li>
<li id="CD016094-bib-0049">
<span class="label">49.</span><cite>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [PMID: ]</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1593914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medical%20Care&amp;title=The%20MOS%2036-item%20short-form%20health%20survey%20(SF-36):%20I.%20Conceptual%20framework%20and%20item%20selection&amp;author=CD%20Sherbourne&amp;volume=30&amp;issue=6&amp;publication_year=1992&amp;pages=473-83&amp;pmid=1593914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0050">
<span class="label">50.</span><cite>Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research 2011;20(10):1727-36. [DOI: 10.1007/s11136-011-9903-x]</cite> [<a href="https://doi.org/10.1007/s11136-011-9903-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3220807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21479777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Quality%20of%20Life%20Research&amp;title=Development%20and%20preliminary%20testing%20of%20the%20new%20five-level%20version%20of%20EQ-5D%20(EQ-5D-5L)&amp;author=M%20Herdman&amp;author=C%20Gudex&amp;author=A%20Lloyd&amp;author=MF%20Janssen&amp;author=P%20Kind&amp;volume=20&amp;issue=10&amp;publication_year=2011&amp;pages=1727-36&amp;pmid=21479777&amp;doi=10.1007/s11136-011-9903-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0051">
<span class="label">51.</span><cite>ICH 1994. ICH harmonised tripartite guideline. Clinical safety data management: definitions and standard for expedited reporting E2A. Step 4 version. In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1994. Available from https://database.ich.org/sites/default/files/E2A_Guideline.pdf.</cite>
</li>
<li id="CD016094-bib-0052">
<span class="label">52.</span><cite>Covidence. Version accessed 4 August 2025. Melbourne, Australia: Veritas Health Innovation, 2025. Available at https://covidence.org.</cite>
</li>
<li id="CD016094-bib-0053">
<span class="label">53.</span><cite>Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34. [DOI: 10.1002/(sici)1097-0258(19981230)17:24%3C2815::aid-sim110%3E3.0.co;2-8]</cite> [<a href="https://doi.org/10.1002/(sici)1097-0258(19981230)17:24%3C2815::aid-sim110%3E3.0.co;2-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9921604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Statistics%20in%20Medicine&amp;title=Extracting%20summary%20statistics%20to%20perform%20meta-analyses%20of%20the%20published%20literature%20for%20survival%20endpoints&amp;author=MK%20Parmar&amp;author=V%20Torri&amp;author=L%20Stewart&amp;volume=17&amp;issue=24&amp;publication_year=1998&amp;pages=2815-34&amp;pmid=9921604&amp;doi=10.1002/(sici)1097-0258(19981230)17:24%3C2815::aid-sim110%3E3.0.co;2-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0054">
<span class="label">54.</span><cite>Review Manager (RevMan). Version 9.7.1. The Cochrane Collaboration, 2025. Available at https://revman.cochrane.org.</cite>
</li>
<li id="CD016094-bib-0055">
<span class="label">55.</span><cite>Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. [DOI: 10.1136/bmj.l4898]</cite> [<a href="https://doi.org/10.1136/bmj.l4898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=RoB%202:%20a%20revised%20tool%20for%20assessing%20risk%20of%20bias%20in%20randomised%20trials&amp;author=JA%20Sterne&amp;author=J%20Savovi%C4%87&amp;author=MJ%20Page&amp;author=RG%20Elbers&amp;author=NS%20Blencowe&amp;volume=366&amp;publication_year=2019&amp;pages=l4898&amp;pmid=31462531&amp;doi=10.1136/bmj.l4898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0056">
<span class="label">56.</span><cite>Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Chapter 8: Assessing risk of bias in a randomized trial (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite>
</li>
<li id="CD016094-bib-0057">
<span class="label">57.</span><cite>Schünemann HJ, Vist GE, Higgins JP, Santesso N, Deeks JJ, Glasziou P, et al. Chapter 15: Interpreting results and drawing conclusions (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite>
</li>
<li id="CD016094-bib-0058">
<span class="label">58.</span><cite>GRADEpro GDT. Version accessed 5 August 2025. Hamilton (ON): McMaster University (developed by Evidence Prime), 2025. Available at https://gradepro.org.</cite>
</li>
<li id="CD016094-bib-0059">
<span class="label">59.</span><cite>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials [Electronic Resource] 2007;7(8):16. [DOI: 10.1186/1745-6215-8-16]</cite> [<a href="https://doi.org/10.1186/1745-6215-8-16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1920534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17555582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trials%20%5BElectronic%20Resource%5D&amp;title=Practical%20methods%20for%20incorporating%20summary%20time-to-event%20data%20into%20meta-analysis&amp;author=JF%20Tierney&amp;author=LA%20Stewart&amp;author=D%20Ghersi&amp;author=S%20Burdett&amp;author=MR%20Sydes&amp;volume=7&amp;issue=8&amp;publication_year=2007&amp;pages=16&amp;pmid=17555582&amp;doi=10.1186/1745-6215-8-16&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0060">
<span class="label">60.</span><cite>Colangelo KJ, Pope JE, Peschkent C. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36. Journal of Rheumatology 2009;36(10):2231-7. [DOI: 10.3899/jrheum.090193]</cite> [<a href="https://doi.org/10.3899/jrheum.090193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19723907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Rheumatology&amp;title=The%20minimally%20important%20difference%20for%20patient%20reported%20outcomes%20in%20systemic%20lupus%20erythematosus%20including%20the%20HAQ-DI,%20pain,%20fatigue,%20and%20SF-36&amp;author=KJ%20Colangelo&amp;author=JE%20Pope&amp;author=C%20Peschkent&amp;volume=36&amp;issue=10&amp;publication_year=2009&amp;pages=2231-7&amp;pmid=19723907&amp;doi=10.3899/jrheum.090193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0061">
<span class="label">61.</span><cite>Page MJ, Higgins JP, Sterne JA. Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (chapter last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite>
</li>
<li id="CD016094-bib-0062">
<span class="label">62.</span><cite>Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368:l6890. [DOI: 10.1136/bmj.l6890]</cite> [<a href="https://doi.org/10.1136/bmj.l6890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7190266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31948937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Synthesis%20without%20meta-analysis%20(SWiM)%20in%20systematic%20reviews:%20reporting%20guideline&amp;author=M%20Campbell&amp;author=JE%20McKenzie&amp;author=A%20Sowden&amp;author=SV%20Katikireddi&amp;author=SE%20Brennan&amp;volume=368&amp;publication_year=2020&amp;pages=l6890&amp;pmid=31948937&amp;doi=10.1136/bmj.l6890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CD016094-bib-0063">
<span class="label">63.</span><cite>Deeks JJ, Higgins JP, Altman DG, McKenzie JE, Veroniki AA, editor(s). Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite>
</li>
<li id="CD016094-bib-0064">
<span class="label">64.</span><cite>Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from https://gdt.gradepro.org/app/handbook/handbook.html.</cite>
</li>
<li id="CD016094-bib-0065">
<span class="label">65.</span><cite>Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024. Available from https://www.training.cochrane.org/handbook.</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p><strong>Supplementary material 1</strong> Search strategies</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12368947/bin/CD016094-SUP-01-searchStrategy.html" data-ga-action="click_feat_suppl" class="usa-link">CD016094-SUP-01-searchStrategy.html</a><sup> (30.2KB, html) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data sharing is not applicable to this article as it is a protocol, so no datasets were generated or analysed.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/14651858.CD016094"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/CD016094.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (214.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368947/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368947/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368947%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368947/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368947/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368947/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40838448/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368947/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40838448/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368947/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368947/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="PmCKRIghNz0DQA4sHEPZP7kVt7bp9MXISlaBz6HZjB2jyZLyDLqhV8jGY2MKWW0V">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
